- A human MYBPC3 mutation appearing about 10 centuries ago results in a hypertrophic cardiomyopathy with delayed onset, moderate evolution but with a risk of sudden deathCarolien H Teirlinck
Laboratoire Cardiogénétique, Centre de biologie et pathologie est, Groupe Hospitalier Est, 59 Boulevard Pinel, Bron, Lyon, 69677, France
BMC Med Genet 13:105. 2012..Hypertrophic Cardiomyopathy (HCM) is a genetically heterogeneous disease. One specific mutation in the MYBPC3 gene is highly prevalent in center east of France giving an opportunity to define the clinical profile of this specific mutation...